Recap: Oncternal Therapeutics Q4 Earnings


Oncternal Therapeutics ONCT reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.


Oncternal Therapeutics missed estimated earnings by -1.0%, reporting an EPS of $-3.11 versus an estimate of $-3.07.

Revenue was up $126 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.6 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Oncternal Therapeutics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -2.8 -3.2 -4 -4.2
EPS Actual -3.4 -3 -4 -4
Revenue Estimate 120K 200K 170K 330K
Revenue Actual 179K 106K 203K 171K

To track all earnings releases for Oncternal Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!